Document
IPR2016-01582, No. 2054-133 Exhibit - JSN 2054 Kuzel et al, ¿¿¿A Phase II Study of Continuous Infusion 5 Fluorouracil in Advanced Hormone Refractory Prostate Cancer,¿¿¿ Cancer, 7261965 19...
Cite Document
IPR2016-01582, No. 2054-133 Exhibit - JSN 2054 Kuzel et al, ¿¿¿A Phase II Study of Continuous Infusion 5 Fluorouracil in Advanced Hormone Refractory Prostate Cancer,¿¿¿ Cancer, 7261965 1968 1993 (P.T.
+ More Snippets
Document
IPR2016-01582, No. 1110-264 Exhibit - Zytiga¿¿ Approved in the EU for Use in the Treatment of Metastatic Castration Resistant Prostate Cancer Before Chemotherapy (P.T.A.B. Apr. 19, 2017)
Cite Document
IPR2016-01582, No. 1110-264 Exhibit - Zytiga¿¿ Approved in the EU for Use in the Treatment of Metastatic Castration Resistant Prostate Cancer Before Chemotherapy (P.T.A.B. Apr. 19, 2017)
+ More Snippets
Document
IPR2016-01582, No. 1042-41 Exhibit - Sartor 2011 (P.T.A.B. Aug. 10, 2016)
Cite Document
IPR2016-01582, No. 1042-41 Exhibit - Sartor 2011 (P.T.A.B. Aug. 10, 2016)
+ More Snippets
Document
IPR2016-01582, No. 1008-7 Exhibit - Attard 2005 (P.T.A.B. Aug. 10, 2016)
Cite Document
IPR2016-01582, No. 1008-7 Exhibit - Attard 2005 (P.T.A.B. Aug. 10, 2016)
+ More Snippets
Document
IPR2016-01582, No. 1002-79 Exhibit - Declaration of Paul A Godley, MD, PhD, MPP (P.T.A.B. Aug. 16, 2016)
Cite Document
IPR2016-01582, No. 1002-79 Exhibit - Declaration of Paul A Godley, MD, PhD, MPP (P.T.A.B. Aug. 16, 2016)
+ More Snippets
Document
IPR2016-01582, No. 1046-45 Exhibit - Scher 2004 (P.T.A.B. Aug. 10, 2016)
Cite Document
IPR2016-01582, No. 1046-45 Exhibit - Scher 2004 (P.T.A.B. Aug. 10, 2016)
+ More Snippets
Document
IPR2016-01582, No. 1011-10 Exhibit - Harris 2002 (P.T.A.B. Aug. 10, 2016)
Cite Document
IPR2016-01582, No. 1011-10 Exhibit - Harris 2002 (P.T.A.B. Aug. 10, 2016)
+ More Snippets
Document
IPR2016-01582, No. 1034-33 Exhibit - Taxotere Prescribing Information 2004 (P.T.A.B. Aug. 10, 2016)
Cite Document
IPR2016-01582, No. 1034-33 Exhibit - Taxotere Prescribing Information 2004 (P.T.A.B. Aug. 10, 2016)
+ More Snippets
Document
IPR2016-01582, No. 2066-145 Exhibit - JSN 2066 Mantero et al, ¿¿¿Long term treatment of mineralocorticoid excess syndromes,¿¿¿ Steroids, 6081 86 1995 (P.T.A.B. Mar. 17, 2017)
Cite Document
IPR2016-01582, No. 2066-145 Exhibit - JSN 2066 Mantero et al, ¿¿¿Long term treatment of mineralocorticoid excess syndromes,¿¿¿ Steroids, 6081 86 1995 (P.T.A.B. Mar. 17, 2017)
+ More Snippets
Document
IPR2016-01582, No. 1013-12 Exhibit - Trump 1989 (P.T.A.B. Aug. 10, 2016)
Cite Document
IPR2016-01582, No. 1013-12 Exhibit - Trump 1989 (P.T.A.B. Aug. 10, 2016)
+ More Snippets
Document
IPR2016-01582, No. 2154-223 Exhibit - JSN 2154 Patent Owner Response in IPR2016 01332 (P.T.A.B. Mar. 17, 2017)
Cite Document
IPR2016-01582, No. 2154-223 Exhibit - JSN 2154 Patent Owner Response in IPR2016 01332 (P.T.A.B. Mar. 17, 2017)
+ More Snippets
Document
IPR2016-01582, No. 2164-233 Exhibit - JSN 2164 July 3, 2013 Notice of Allowance from prosecution history of¿¿¿438 patent (P.T.A.B. Mar. 17, 2017)
Cite Document
IPR2016-01582, No. 2164-233 Exhibit - JSN 2164 July 3, 2013 Notice of Allowance from prosecution history of¿¿¿438 patent (P.T.A.B. Mar. 17, 2017)
+ More Snippets
Document
IPR2016-01582, No. 1056-55 Exhibit - FDA News Release Dec 10, 2012 (P.T.A.B. Aug. 10, 2016)
Cite Document
IPR2016-01582, No. 1056-55 Exhibit - FDA News Release Dec 10, 2012 (P.T.A.B. Aug. 10, 2016)
+ More Snippets
Document
IPR2016-01582, No. 1082-241 Exhibit - Montgomery 2016 (P.T.A.B. Apr. 19, 2017)
Cite Document
IPR2016-01582, No. 1082-241 Exhibit - Montgomery 2016 (P.T.A.B. Apr. 19, 2017)
+ More Snippets
Document
IPR2016-01582, No. 2068-147 Exhibit - JSN 2068 Swartz and Dluhy, ¿¿¿Corticosteroids Clinical Pharmacology and Therapeutic Use,¿¿¿ Drugs, 16238 255 1978 (P.T.A.B. Mar. 17, 2017)
Cite Document
IPR2016-01582, No. 2068-147 Exhibit - JSN 2068 Swartz and Dluhy, ¿¿¿Corticosteroids Clinical Pharmacology and Therapeutic Use,¿¿¿ Drugs, 16238 255 1978 (P.T.A.B. Mar. 17, 2017)
+ More Snippets